English | Español

Pharmaceuticals

+ Pharmaceuticals
Patient Daily | Mar 25, 2026

Oral semaglutide does not slow early Alzheimer’s decline in phase 3 trials, study finds
+ Pharmaceuticals
Patient Daily | Mar 25, 2026

GLP-1 drugs cut heart and kidney risks in type 1 diabetes study
+ Pharmaceuticals
Patient Daily | Mar 25, 2026

Experts discuss evolving guidelines for blood pressure control in older adults
+ Pharmaceuticals
Patient Daily | Mar 25, 2026

Losing health insurance worsens diabetes outcomes in low-income adults
+ Pharmaceuticals
Patient Daily | Mar 25, 2026

Study finds addiction risk tied to reward and impulse genes
+ Pharmaceuticals
Patient Daily | Mar 24, 2026

Researchers identify new immune response mechanism with implications for cancer treatment
+ Community
Patient Daily | Mar 23, 2026

Registration opens for Bridgeport Hospital Milford Campus 2026 Mother’s Day Run/Walk events
+ Community
Patient Daily | Mar 23, 2026

Bridgeport Hospital expands prehospital blood transfusion program with new equipment investment

Trending
+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
Patient Daily reports | Aug 10, 2026

SoCal Breathe Free warns persistent sinus symptoms may signal chronic inflammation
+ Regulatory
M. Y. Bailey | Aug 7, 2026

PhRMA's Zirkelbach: 340B program has changed dramatically with 'little transparency into how patients benefit'
+ Pharmaceuticals
Patient Daily | Aug 7, 2026

Researchers develop computer model linking brain chemistry to neural activity patterns